NCT02119793View on ClinicalTrials.gov

Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 Study
Interventions
DEVICE

YVOIRE contour

YVOIRE contour injection into the anteromedial malar region

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY

NCT02119793 - Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour Injected Into the Anteromedial Malar Region in Subjects Who Have Completed the LG-HACL014 Study | Biotech Hunter | Biotech Hunter